Syndax Pharmaceuticals, Inc. (SNDX)
9.54
+0.17
(+1.81%)
USD |
NASDAQ |
Nov 06, 16:00
9.79
+0.25
(+2.62%)
After-Hours: 20:00
Syndax Pharmaceuticals Total Assets (Quarterly) : 692.67M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 692.67M |
| June 30, 2026 | 703.65M |
| March 31, 2026 | 472.67M |
| December 31, 2025 | 529.71M |
| September 30, 2025 | 551.79M |
| June 30, 2025 | 596.15M |
| March 31, 2025 | 640.71M |
| December 31, 2024 | 724.82M |
| September 30, 2024 | 425.81M |
| June 30, 2024 | 476.95M |
| March 31, 2024 | 543.03M |
| December 31, 2023 | 612.88M |
| September 30, 2023 | 399.22M |
| June 30, 2023 | 431.34M |
| March 31, 2023 | 459.83M |
| December 31, 2022 | 497.24M |
| September 30, 2022 | 359.69M |
| June 30, 2022 | 406.44M |
| March 31, 2022 | 422.22M |
| December 31, 2021 | 449.66M |
| September 30, 2021 | 239.50M |
| June 30, 2021 | 263.06M |
| March 31, 2021 | 279.67M |
| December 31, 2020 | 300.61M |
| September 30, 2020 | 179.31M |
| Date | Value |
|---|---|
| June 30, 2020 | 192.63M |
| March 31, 2020 | 105.16M |
| December 31, 2019 | 63.52M |
| September 30, 2019 | 76.38M |
| June 30, 2019 | 87.39M |
| March 31, 2019 | 99.39M |
| December 31, 2018 | 83.94M |
| September 30, 2018 | 96.47M |
| June 30, 2018 | 105.37M |
| March 31, 2018 | 119.96M |
| December 31, 2017 | 137.19M |
| September 30, 2017 | 124.49M |
| June 30, 2017 | 134.67M |
| March 31, 2017 | 97.67M |
| December 31, 2016 | 109.01M |
| September 30, 2016 | 117.73M |
| June 30, 2016 | 127.86M |
| March 31, 2016 | 136.26M |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | 12.33M |
| June 30, 2014 | 9.66M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| Emergent BioSolutions, Inc. | 995.20M |
| Incyte Corp. | 7.287B |
| Vertex Pharmaceuticals, Inc. | 32.74B |
| Travere Therapeutics, Inc. | 848.23M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 709.85M |
| Shareholders Equity (Quarterly) | -17.18M |
| Debt to Equity Ratio | -34.31 |
| Current Ratio | 4.691 |
| Net Debt Paydown Yield | -2.88% |